SEARCH

SEARCH BY CITATION

References

  • Addiego, J.E. , Gomperts, E. , Liu, S.-L. , Bailey, P. , Courter, S.G. , Lee, M.L. , Neslund, G.G. , Kingdon, H.S. & Griffith, M.J. (1992) Treatment of hemophilia A with highly purified factor VIII concentrate prepared by anti-FVIIIc immunoaffinity chromatography. Thrombosis and Haemostasis, 117, 1927.
  • Barrowcliffe, T.W. (1993) Recommendations for the assay of high purity Factor VIII concentrates. Thrombosis and Haemostasis, 117, 876877.
  • Barrowcliffe, T.W. (1996) Factor VIII activity assay. Establishment of a reference preparation and evaluation of a chromogenic method. Pharmeuropa Special Issue BIO, 117, 3947.
  • Barrowcliffe, T.W. , Watton, J. , Harman, A. , Tubbs, J.E. & Kemball-Cook, G. (1990) Potency of high purity FVIII concentrates. Lancet, 117, 124.
  • Barrowcliffe, T.W. , Raut, S. & Hubbard, A.R. (1998) Discrepancies in potency assessment of recombinant FVIII concentrates. Haemophilia, 117, 634640.
  • European Pharmacopoeia (2002) 4th edn. Assay of Blood Coagulation Factor VIII. Methods of Analysis 2.7.4. Council of Europe, Strasbourg.
  • Sandberg, H. , Almstedt, A. , Brandt, J. , Gray, E. , Holmquist, L. , Oswaldsson, U. , Sebring, S. & Mikaelsson, M. (2001) Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ. Thrombosis and Haemostasis, 117, 93100.